Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Cavalier currently holds 518,547 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Cavalier has been a net seller of LYRA stock. They have purchased $0 and sold $8.7K worth of shares.
Jason Cavalier's most recent insider trade was on Jan 6, 2026, when they sold 769 shares at $3.36 per share.
Jason Cavalier serves as Executive at Lyra Therapeutics, Inc. (LYRA). They have executed 3 insider transactions totaling $8.7K over their tenure at the company.
Jason Cavalier holds the position of Executive at Lyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Jason Cavalier has shown a selling trading pattern, with $0 in total purchases and $8.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Cavalier was on Jul 10, 2025, when they sold $6.1K worth of LYRA shares. This transaction involved 684 shares at $8.91 per share.
Jason Cavalier currently owns 518,547 shares of Lyra Therapeutics, Inc. (LYRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Cavalier's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Cavalier has 3 Form 4 filings on record as an insider at Lyra Therapeutics, Inc..
Set alerts for Jason Cavalier and 40,000+ other insiders.